Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · November 02, 2011

Vandetanib Effective in Advanced Medullary Thyroid Cancer

Journal of Clinical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
J. Clin. Oncol 2011 Oct 24;[EPub Ahead of Print], SA Wells Jr, BG Robinson, RF Gagel, H Dralle, JA Fagin, M Santoro, E Baudin, R Elisei, B Jarzab, JR Vasselli, J Read, P Langmuir, AJ Ryan, MJ Schlumberger

Further Reading